「Low RAI2 expression is a marker of poor prognosis in breast cancer<Abstract of dissertation>」の関連論文
-
A novel urinary microRNA biomarker panel for detecting gastric cancer
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
Circulating microRNA/isomiRs as novel biomarkers of esophageal squamous cell carcinoma
-
The mechanistic role of fatty acid binding protein 7 (FABP7) in tumor proliferation
-
Heat shock protein 105 peptide vaccine could induce antitumor immune reactions in a phase I clinical trial
-
Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma (本文)
-
Cutaneous T-cell-attracting chemokine as a novel biomarker for predicting prognosis of idiopathic pulmonary fibrosis: a prospective observational study
-
Relationship between presarcopenia and event occurrence in patients with primary hepatocellular carcinoma
-
Interleukin (IL)-17A is a potent prognostic factor associated with intratumoral neutrophil infiltration and C-X-C chemokine motif ligand 1 in triple-negative breast cancer
-
A High C-Reactive Protein Level on Postoperative Day 7 is Associated with Poor Survival of Patients with Pancreatic Ductal Adenocarcinoma after Resection.
-
Novel Breast Cancer Brain Metastasis Patient-Derived Orthotopic Xenograft Model for Preclinical Studies
-
CHAMP1 expression is upregulated in cancer and supports cell growth
-
Predictive Ability of Preoperative PT-INR and Postoperative MCP1 for Post-hepatectomy Liver Failure
-
Cooperative participation of epigenomic and genomic alterations in the clinicopathological diversity of gastric adenocarcinomas : significance of cell adhesion and epithelial–mesenchymal transition-related signaling pathways (本文)
-
Regulation of Cell Motility by La-Related Protein 4 in Ovarian Cancer Cell
-
The Roles of Cancer-Associated Fibroblasts in Colorectal Carcinogenesis
-
Soluble PD-L1 Expression in Circulation as a Predictive Marker for Recurrence and Prognosis in Gastric Cancer: Direct Comparison of the Clinical Burden Between Tissue and Serum PD-L1 Expression
-
Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors (本文)
-
Association of CD4-positive cell infiltration with response to vedolizumab in patients with ulcerative colitis
-
The baseline recurrence risk of patients with intermediate-risk cervical cancer.
-
Mutation burden-orthogonal tumor genomic subtypes delineate responses to immune checkpoint therapy
-
The expression of carcinoembryonic antigen mRNA in the lavage of the dissected area of the lateral lymph nodes influences the lateral recurrence of lower rectal cancer
-
Trp53 Mutation in Keratin 5 (Krt5)-Expressing Basal Cells Facilitates the Development of Basal Squamous-Like Invasive Bladder Cancer in the Chemical Carcinogenesis of Mouse Bladder
-
Occurrence of cholangiocarcinoma, three years after negative seroconversion of anti-TIF1γ antibody, in a dermatomyositis patient
-
Metastases of soft tissue sarcoma to the liver: A Historical Cohort Study from a Hospital-based Cancer Registry
-
Radiotherapy alone for stage IE ocular adnexal mucosa-associated lymphoid tissue lymphomas : long-term results
-
Platelets enhance malignant behaviours of gastric cancer cells via direct contacts
-
Anti-Allergic Drug Suppressed Pancreatic Carcinogenesis via Down-Regulation of Cellular Proliferation
-
Risk factors for cisplatin-induced acute kidney injury: A pilot study on the usefulness of genetic variants for predicting nephrotoxicity in clinical practice
-
Differentiation of Kawasaki disease from other causes of fever and cervical lymphadenopathy : a diagnostic scoring system using contrast-enhanced CT
-
The impact of contour maps on estimating the risk of gastrointestinal stromal tumor recurrence: indications for adjuvant therapy: an analysis of the Kinki GIST registry
-
The loss of endothelin-2 exhibits an anticancer effect in A549 human lung adenocarcinoma cell line
-
Comparison of efficacy and safety outcomes of anticancer drugs between Japanese patients and the overall population in multi-regional clinical trials
-
Next Generation Sequencing-Based Transcriptome Predicts Bevacizumab Efficacy in Combination with Temozolomide in Glioblastoma
-
CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy
-
The role of histone lysine demethylase 2B in the pathology of canine hemangiosarcoma
-
Comprehensive analysis of circulating microRNAs as predictive biomarkers for sorafenib therapy outcome in hepatocellular carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
SPC18 expression is an independent prognostic indicator of patients with esophageal squamous cell carcinoma
-
A large-scale targeted proteomics of plasma extracellular vesicles shows utility for prognosis prediction subtyping in colorectal cancer
-
A case of simultaneous breast cancer and ovarian cancer based on a hereditary breast and ovarian cancer syndrome
-
The treatment strategy of R0 resection in colorectal cancer with synchronous para-aortic lymph node metastasis
-
Post-induction MRD by FCM and GATA1-PCR are significant prognostic factors for myeloid leukemia of Down syndrome.
-
Real-world application of next-generation sequencing-based test for surgically resectable colorectal cancer in clinical practice (本文)
-
Involvement of Transcription Factor 21 in the Pathogenesis of Fibrosis in Endometriosis
-
Compromised anti-tumor–immune features of myeloid cell components in chronic myeloid leukemia patients
-
Controlling lymph node micrometastases by neoadjuvant chemotherapy affects the prognosis in advanced esophageal squamous cell carcinoma
-
In vivo induction of activin A-producing alveolar macrophages supports the progression of lung cell carcinoma
-
Optimal use of anthracycline-free perioperative chemotherapy in HER2-positive breast cancer patients (本文)
-
Biological and clinical significance of the YKL-40/osteopontin–integrin β4–p70S6K axis induced by macrophages in early oesophageal squamous cell carcinoma